Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
We describe six patients (five women and one man; median age, 47 years; range, 39 to 54) with postprandial symptoms of neuroglycopenia owing to endogenous hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass surgery. Except for equivocal evidence in one patient, there was no radiologic evidence of insulinoma. Selective arterial calcium-stimulation tests, positive in each patient, were used to guide partial pancreatectomy. Nesidioblastosis was identified in resected specimens from each patient, and multiple insulinomas were identified in one. Hypoglycemic symptoms diminished postoperatively. We speculate that hyperfunction of pancreatic islets did not lead to obesity but that beta-cell trophic factors may have increased as a result of gastric bypass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some persons who have undergone Roux-en-Y gastric bypass for obesity have endogenous hyperinsulinemic hypoglycemia most often due to pancreatic islet nesidioblastosis, but occasionally due to an insulinoma (48 -50).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [48]
In the citing paper
“However, it is the procedure of choice for confirming noninsulinoma pancreatogenous hypoglycemia (15,(43)(44)(45) and post Roux-en-Y gastric bypass hypoglycemia (48 -50) because standard imaging is negative in those disorders.”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [48]
In the citing paper
“post-RYGB hyperinsulinemic hypoglycemia may involve β-cell hypertrophy or neogenesis as well ( 80 , 81 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [80]
Citations
Cites
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664
Steinbrook, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048029 · Cited by 592
Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0015 · Cited by 540
The Escalating Pandemics of Obesity and Sedentary Lifestyle: A Call to Action for Clinicians
Manson, J. E., Skerrett, P. J., Greenland, P., & VanItallie, T. B. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.249 · Cited by 504
Solcia, E., Capella, C., & Klöppel, G. (1997) · Medical Entomology and Zoology · Cited by 481
Zhou, J., Wang, X., Pineyro, M. A., & Egan, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2358 · Cited by 319
Foulis, A. K. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199806)185:2<227::aid-path103>3.0.co;2-r · Cited by 212
Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Self-citationSigstad, H. (1970) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1970.tb08072.x · Cited by 176
Research works printed but not linked: 3
- Threatte GA, Henry JB. Carbohydrates. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: W.B. Saunders, 1996:194-207.
- Kao PC, 1992, Ann Clin Lab Sci, 22, 307
- Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: W.B. Saunders, 1999:750-808.
Cited by
Items 101–200 of 786
The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control
Douros, J. D., Tong, J., & D’Alessio, D. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00183 · Cited by 106
Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia
Roslin, M. S., Damani, T., Oren, J. H., Andrews, R. A. F., Yatco, E., & Shah, P. C. (2010) · Surgical Endoscopy · doi:10.1007/s00464-010-1489-9 · Cited by 100
“The clinical severity of this syndrome varies, with some authors reporting profound symptoms of hypoglycemia, leading them to propose partial pancreatectomy for treatment [ 8 ].”
BackgroundAbrahamsson, N., Engström, B. E., Sundbom, M., & Karlsson, F. A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0504 · Cited by 99
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 110
Valderas, J. P., Ahuad, J., Rubio, L., Escalona, M., Pollak, F., & Maiz, A. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0581-0 · Cited by 97
“However, the existence of nesidioblastosis following RYGBP in human subjects is a matter of controversy between researchers [16–18].”
BackgroundVidal, J., Nicolau, J., Romero, F., Casamitjana, R., Momblan, D., Conget, I., Morínigo, R., & Lacy, A. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1620 · Cited by 94
Incretin Effects on β-Cell Function, Replication, and Mass
Garber, A. J. (2011) · Diabetes Care · doi:10.2337/dc11-s230 · Cited by 92
Successful Medical Management of Status Post-Roux-en-Y-Gastric-Bypass Hyperinsulinemic Hypoglycemia
Spanakis, E., & Gragnoli, C. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9888-5 · Cited by 92
“Several case reports and case series studies have described a rare but extremely interesting complication of RYGBP, status postgastric-bypass hyperinsulinemic hypoglycemia [3–8].”
BackgroundRole of 18 F‐ FDOPA PET / CT imaging in endocrinology
Santhanam, P., & Taïeb, D. (2014) · Clinical Endocrinology · doi:10.1111/cen.12566 · Cited by 92
Whitson, B. A., Leslie, D. B., Kellogg, T. A., Maddaus, M. A., Buchwald, H., Billington, C. J., & Ikramuddin, S. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.02.022 · Cited by 99
Effect of gastric bypass surgery on the incretins
Laferrère, B. (2009) · Diabetes & Metabolism · doi:10.1016/s1262-3636(09)73458-5 · Cited by 90
Benchmarking Best Practices in Weight Loss Surgery
Lim, R. B., Blackburn, G. L., & Jones, D. B. (2010) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2009.11.003 · Cited by 97
Continuous Glucose Monitoring for Evaluation of Glycemic Excursions after Gastric Bypass
Halperin, F., Patti, M. E., Skow, M., Bajwa, M., & Goldfine, A. B. (2011) · Journal of Obesity · doi:10.1155/2011/869536 · Cited by 90
“Additionally, rarely patients may develop hyperinsulinemic hypoglycemia with neuroglycopenia that typically presents 2–5 years postoperatively [9–11].”
BackgroundResultDiabetes remission after bariatric surgery: is it just the incretins?
Laferrère, B. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.143 · Cited by 88
Echeverri, G. J., Mcgrath, K., Bottino, R., Hara, H., Dons, E. M., van der Windt, D. J., Ekser, B., Casu, A., Houser, S. L., Ezzelarab, M. B., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02815.x · Cited by 90
Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery
Malik, S., Mitchell, J. E., Steffen, K., Engel, S., Wiisanen, R., Garcia, L., & Malik, S. A. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.07.003 · Cited by 86
Medical management of patients after bariatric surgery: Principles and guidelines
Elrazek, A. E. A., Elbanna, A., & Bilasy, S. E. (2014) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v6.i11.220 · Cited by 91
Strader, A. D., Clausen, T. R., Goodin, S., & Wendt, D. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9754-x · Cited by 94
“Widespread use of ileal interposition in humans should be approached with caution since the elevations in GLP-1 followinggastric bypass surgery has been implicated in post-surgical reports of hyperinsulinemic hypoglycemia with nesidioblastosis [ 27 ].”
BackgroundRumilla, K. M., Erickson, L. A., Service, F. J., Vella, A., Thompson, G. B., Grant, C. S., & Lloyd, R. V. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.169 · Cited by 85
“1 In the past few years an increasing number of patients with severe hypoglycemia including neuroglycopenia as a result of endogenous hyperinsulinemia in the postgastric bypass setting have been reported”
BackgroundSelf-citationVilallonga, R., van de Vrande, S., & Himpens, J. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-3087-0 · Cited by 85
Abdominal pain after gastric bypass: suspects and solutions
Greenstein, A. J., & O’Rourke, R. W. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.05.007 · Cited by 85
Gastric Bypass and Nesidioblastosis — Too Much of a Good Thing for Islets?
Cummings, D. E. (2005) · New England Journal of Medicine · doi:10.1056/nejme058170 · Cited by 85
Hypoglycemia after Roux-en-Y Gastric Bypass: The BOLD Experience
Sarwar, H., Chapman, W. H. H., Pender, J. R., Ivanescu, A. E., Drake, A. J., Pories, W. J., & Dar, M. S. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1260-8 · Cited by 84
Bariatric surgery and diabetes remission: Sleeve gastrectomy or mini-gastric bypass?
Milone, M., Minno, M. N. D. D., Leongito, M., Maietta, P., Bianco, P., Taffuri, C., Gaudioso, D., Lupoli, R., Savastano, S., Milone, F., et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i39.6590 · Cited by 86
Hofsø, D., Jenssen, T., Bollerslev, J., Ueland, T., Godang, K., Stumvoll, M., Sandbu, R., Røislien, J., & Hjelmesæth, J. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0804 · Cited by 83
Hyperinsulinemic Hypoglycemia Developing Late after Gastric Bypass
Bantle, J., Ikramuddin, S., Kellogg, T., & Buchwald, H. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9102-6 · Cited by 79
Rabiee, A., Magruder, J. T., Salas-Carrillo, R., Carlson, O., Egan, J. M., Askin, F. B., Elahi, D., & Andersen, D. K. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2010.09.047 · Cited by 80
“Reports have described a handful of patients in whom frank hypoglycemic episodes, some resulting in motor vehicle accidents, have occurred 1 to 3 y after RYGB [1–5].”
BackgroundInfluentialAlexandrides, T. K., Skroubis, G., & Kalfarentzos, F. E. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9044-z · Cited by 82
Emous, M., Wolffenbuttel, B. H. R., Totté, E., & van Beek, A. P. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.04.028 · Cited by 89
Thompson, S. M., Vella, A., Thompson, G. B., Rumilla, K. M., Service, F. J., Grant, C. S., & Andrews, J. C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2404 · Cited by 80
Self-citationRheinwalt, K. P., Plamper, A., Rückbeil, M. V., Kroh, A., Neumann, U. P., & Ulmer, T. F. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04250-3 · Cited by 87
Gastric Bypass Improves β-Cell Function and Increases β-Cell Mass in a Porcine Model
Lindqvist, A., Spégel, P., Ekelund, M., Garcia‐Vaz, E., Pierzynowski, S. G., Gomez, M. F., Mulder, H., Hedenbro, J., Groop, L., & Wierup, N. (2014) · Diabetes · doi:10.2337/db13-0969 · Cited by 80
Innovative imaging of insulinoma: the end of sampling? A review
Christ, E., Antwi, K., Fani, M., & Wild, D. (2020) · Endocrine-Related Cancer · doi:10.1530/erc-19-0476 · Cited by 78
Postprandial Dysmetabolism: the Missing Link Between Diabetes and Cardiovascular Events?
Bell, D. S. H., O’Keefe, J. H., & Jellinger, P. S. (2008) · Endocrine Practice · doi:10.4158/ep.14.1.112 · Cited by 82
Myint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1065 · Cited by 77
Lee, W.-J., Chong, K., Chen, C.-Y., Chen, S. C., Lee, Y. C., Ser, K., & Chuang, L. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0401-6 · Cited by 82
“A possible mechanism for the increase in insulin secretion is due to the increase in beta cell mass through “nesidioblastosis” [36].”
BackgroundRoux-en-Y gastric bypass reversal: a systematic review
Shoar, S., Nguyen, T., Ona, M. A., Reddy, M., Anand, S., Al-Kuwari, M., & Saber, A. A. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.023 · Cited by 77
“An association between RYGB and postprandial hypoglycemia with nesidioblastosis has been reported as a potential complication after gastric bypass surgery [46].”
BackgroundPostprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment
Mala, T. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.01.010 · Cited by 75
“The extensive use of RYGB thus makes this complication clinically relevant [1,5,6].”
BackgroundObesity and Diabetes: The Impact of Bariatric Surgery on Type‐2 Diabetes
Dixon, J. B. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0062-y · Cited by 89
Neuroendocrine Neoplasms of the Pancreas
Markow, M., & Centeno, B. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3426-3_13 · Cited by 74
“genase, causing increased α-ketoglutarate and effi cacy of insulin secretion that is stimulated by amino acids [ 99 ].”
Calcineurin/NFAT signaling in the β‐cell: From diabetes to new therapeutics
Heit, J. J. (2007) · BioEssays · doi:10.1002/bies.20644 · Cited by 82
Ritz, P., Vaurs, C., Bertrand, M., Anduze, Y., Guillaume, E., & Hanaire, H. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0302 · Cited by 74
Approach to the patient with spontaneous hypoglycemia
Martens, P., & Tits, J. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.02.011 · Cited by 79
“Heighted attention to the entity of NIPHS led to the recognition of similar clinical findings (severe neuroglycopenic symptoms) in patients with a history of gastric bypass surgery [34–37].”
Background7. Obesity Management for the Treatment of Type 2 Diabetes
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s010 · Cited by 88
Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
Körner, M., Christ, E., Wild, D., & Reubi, J. C. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00158 · Cited by 73
Liraglutide Effect and Action in Diabetes (LEAD™) trial
Madsbad, S. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.119 · Cited by 77
Lee, C. J., Wood, G. C., Lazo, M., Brown, T. T., Clark, J. M., Still, C., & Benotti, P. (2016) · Obesity · doi:10.1002/oby.21479 · Cited by 70
Craig, C. M., Lawler, H. M., Lee, C. J. E., Tan, M., Davis, D. B., Tong, J., Glodowski, M., Rogowitz, E., Karaman, R., McLaughlin, T. L., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab103 · Cited by 69
Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1
Patti, M.-E., & Goldfine, A. B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.038 · Cited by 68
Best Practice Updates for Multidisciplinary Care in Weight Loss Surgery
Apovian, C. M., Cummings, S., Anderson, W., Borud, L., Boyer, K., Day, K., Hatchigian, E., Hodges, B., Patti, M. E., Pettus, M., et al. (2009) · Obesity · doi:10.1038/oby.2008.580 · Cited by 65
Raverdy, V., Baud, G., Pigeyre, M., Verkindt, H., Torres, F., Preda, C., Thuillier, D., Gélé, P., Vantyghem, M.-C., Caiazzo, R., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001915 · Cited by 65
Yu, R., Nissen, N. N., Dhall, D., & Heaney, A. P. (2008) · Pancreas · doi:10.1097/mpa.0b013e31815ceb23 · Cited by 68
Guettier, J.-M., & Gorden, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.005 · Cited by 68
Vanderveen, K. A., Grant, C. S., Thompson, G. B., Farley, D. R., Richards, M. L., Vella, A., Vollrath, B., & Service, F. J. (2010) · Surgery · doi:10.1016/j.surg.2010.09.027 · Cited by 67
Self-citationShort-, Mid- and Long-Term Results of Larrad Biliopancreatic Diversion
Larrad-Jiménez, Á., Sánchez-Cabezudo Díaz-Guerra, C., de Cuadros Borrajo, P., Bretón Lesmes, I., & Moreno Esteban, B. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9035-0 · Cited by 67
Endocrine and Metabolic Complications After Bariatric Surgery
Jammah, A. A. (2015) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.164183 · Cited by 80
Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor
Holst, J. J., & Madsbad, S. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.033 · Cited by 67
Hyperinsulinemic Hypoglycemia – The Molecular Mechanisms
Nessa, A., Rahman, S. A., & Hussain, K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00029 · Cited by 72
Cui, Y., Elahi, D., & Andersen, D. K. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1585-8 · Cited by 67
Hypoglycemia in everyday life after gastric bypass and duodenal switch
Abrahamsson, N., Edén Engström, B., Sundbom, M., & Karlsson, F. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0821 · Cited by 63
The Change in the Dumping Syndrome Concept
Deitel, M. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9756-8 · Cited by 75
“To determine the location of hyperfunctioning beta cells, selective arterial calcium stimulation, with venous sampling of the mesenteric vessels (for pancreatic body and head) and of the splenic vein (for tail), has been utilized [ 17 , 19] but has not been found to be diagnostic [20].”
MethodHormonal Response to a Mixed-Meal Challenge After Reversal of Gastric Bypass for Hypoglycemia
Lee, C. J., Brown, T., Magnuson, T. H., Egan, J. M., Carlson, O., & Elahi, D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1151 · Cited by 65
GLP-1: A Mediator of the Beneficial Metabolic Effects of Bariatric Surgery?
Manning, S., Pucci, A., & Batterham, R. L. (2015) · Physiology · doi:10.1152/physiol.00027.2014 · Cited by 63
Tharakan, G., Behary, P., Wewer Albrechtsen, N. J., Chahal, H., Kenkre, J., Miras, A. D., Ahmed, A. R., Holst, J. J., Bloom, S. R., & Tan, T. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0446 · Cited by 61
Davis, D. B., Khoraki, J., Ziemelis, M., Sirinvaravong, S., Han, J. Y., & Campos, G. M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.011 · Cited by 60
Meier, J. J., Nauck, M. A., & Butler, P. C. (2006) · Diabetologia · doi:10.1007/s00125-005-0114-2 · Cited by 64
Patti, M. E., Li, P., & Goldfine, A. B. (2015) · Obesity · doi:10.1002/oby.21043 · Cited by 62
Reubi, J., Perren, A., Rehmann, R., Waser, B., Christ, E., Callery, M., Goldfine, A., & Patti, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1901-y · Cited by 64
“In some individuals with this syndrome, diffuse islet cell hyperplasia and expansion of beta cell mass has been observed [ 9 , 10]; in other studies, increased nuclear size relative to body mass, but not hyperplasia has been reported [7].”
BackgroundMethodInfluentialKoehler, J. A., & Drucker, D. J. (2006) · Diabetes · doi:10.2337/db05-1145 · Cited by 60
Incretin Hypersecretion in Post-Gastric Bypass Hypoglycemia—Primary Problem or Red Herring?
Vella, A., & Service, F. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2260 · Cited by 63
Self-citationBellin, M. D., Parazzoli, S., Oseid, E., Bogachus, L. D., Schuetz, C., Patti, M. E., Dunn, T., Pruett, T., Balamurugan, A. N., Hering, B., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12776 · Cited by 61
Body Mass Index and Outcomes from Pancreatic Resection: a Review and Meta-analysis
Ramsey, A. M., & Martin, R. C. G. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1502-1 · Cited by 65
Kim, S. H., Liu, T. C., Abbasi, F., Lamendola, C. A., Morton, J. M., Reaven, G. M., & McLaughlin, T. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9893-8 · Cited by 63
“On the other hand, there are a total of only 30 unique patients with neuroglycopenia post-RYGB who have been described in the literature [ 2 , 3, 14].”
BackgroundHypoglycaemia related to inherited metabolic diseases in adults
Douillard, C., Mention, K., Dobbelaere, D., Wemeau, J.-L., Saudubray, J.-M., & Vantyghem, M.-C. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-26 · Cited by 60
“[55], in which GLP-1 plays a role.”
Female Reproductive Issues Following Bariatric Surgery
Wax, J. R., Pinette, M. G., Cartin, A., & Blackstone, J. A. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000279291.86611.46 · Cited by 67
Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia
Mathavan, V. K., Arregui, M., Davis, C., Singh, K., Patel, A., & Meacham, J. (2010) · Surgical Endoscopy · doi:10.1007/s00464-010-1001-6 · Cited by 61
“A subsequent increase in beta cell mass might lead to inappropriate insulin release in response to carbohydrate meal [4–6].”
BackgroundMethodResultInfluentialAlvarez, G. C., Faria, E. N., Beck, M., Girardon, D. T., & Machado, A. C. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9096-0 · Cited by 61
Palladino, A. A., Sayed, S., Levitt Katz, L. E., Gallagher, P. R., & De León, D. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1263 · Cited by 61
“An exaggerated incretin and insulin response has been described to be part of the pathophysiology in these patients (7, 8), as well as pancreatic islet hyperplasia (5, 6).”
BackgroundPathologic pancreatic endocrine cell hyperplasia
Ouyang, D. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i2.137 · Cited by 62
Bariatric surgery: a best practice article
Neff, K. J. H., & le Roux, C. W. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200798 · Cited by 55
Pancreatic neuroendocrine tumors
Krampitz, G. W., & Norton, J. A. (2013) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2013.08.001 · Cited by 64
Diagnostic tools for post‐gastric bypass hypoglycaemia
Emous, M., Ubels, F. L., & van Beek, A. P. (2015) · Obesity Reviews · doi:10.1111/obr.12307 · Cited by 58
Hypoglycemia complicating bariatric surgery: incidence and mechanisms
Foster‐Schubert, K. E. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32834449b9 · Cited by 64
Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?
Cohen, D. R. (2013) · BMJ · doi:10.1136/bmj.f3680 · Cited by 58
Gastrointestinal Surgery as a Treatment for Diabetes
Cummings, D. E., & Flum, D. R. (2008) · JAMA · doi:10.1001/jama.299.3.341 · Cited by 62
Post-bypass hypoglycaemia: A review of current findings
Ritz, P., & Hanaire, H. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.04.003 · Cited by 56
Management of the Metabolic/Bariatric Surgery Patient
Buchwald, H., Ikramuddin, S., Dorman, R. B., Schone, J. L., & Dixon, J. B. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.05.035 · Cited by 65
Dapri, G., Cadière, G. B., & HIMPENS, J. M. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0252-6 · Cited by 58
“There is no question that these less aggressive methods should be attempted before possible pancreatic lesions are investigated [ 16 , 17].”
BackgroundCeppa, E. P., Ceppa, D. P., Omotosho, P. A., Dickerson, J. A., Park, C. W., & Portenier, D. D. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.08.008 · Cited by 59
Asymptomatic Hyperinsulinemic Hypoglycemia after Gastric Banding
Scavini, M., Pontiroli, A. E., & Folli, F. (2005) · New England Journal of Medicine · doi:10.1056/nejmc052356 · Cited by 55
Bariatric surgery and obesity: influence on the incretins
Laferrère, B. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.8 · Cited by 57
The Hundred Most Cited Articles in Bariatric Surgery
Ahmad, S. S., Ahmad, S., Kohl, S., Ahmad, S., & Ahmed, A. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1542-1 · Cited by 58
What should be done in an operating room when an insulinoma cannot be found?
Rostambeigi, N., & Thompson, G. B. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03527.x · Cited by 53
Self-citationDo we really know why diabetes remits after gastric bypass surgery?
Laferrère, B. (2011) · Endocrine · doi:10.1007/s12020-011-9514-x · Cited by 52
“It remains unknown whether the exaggerated incretin response observed early after GBP, accompanied by improved post-prandial insulin and glucose levels is responsible for the later development of hyperinsulinemic hypoglycemia with [33] or without [34] nesidioblastosis.”
Ileal transposition provides insight into the effectiveness of gastric bypass surgery
Strader, A. D. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.034 · Cited by 53
Fenske, W. K., Bueter, M., Miras, A. D., Ghatei, M. A., Bloom, S. R., & le Roux, C. W. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.126 · Cited by 57
“33 The underlying mechanisms causing pancreatic nesidioblastosis after gastric bypas”
BackgroundAbnormal glucose tolerance testing after gastric bypass
Roslin, M. S., Oren, J. H., Polan, B. N., Damani, T., Brauner, R., & Shah, P. C. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.023 · Cited by 52
Hazlehurst, J., Khoo, B. C. E., Lobato, C. B., Ilesanmi, I., Abbott, S., Chan, T. L., Pillai, S., Maslin, K., Purkayastha, S., McGowan, B. M., et al. (2024) · Endocrine Connections · doi:10.1530/ec-23-0285 · Cited by 58
The treatment of hyperinsulinemic hypoglycaemia in adults: an update
On behalf of NIKE Group, Davi′, M. V., Pia, A., Guarnotta, V., Pizza, G., Colao, A., & Faggiano, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0536-3 · Cited by 51
Incidence and Predictors of Hypoglycemia 1 Year After Laparoscopic Sleeve Gastrectomy
Belligoli, A., Sanna, M., Serra, R., Fabris, R., Prà, C. D., Conci, S., Fioretto, P., Prevedello, L., Foletto, M., Vettor, R., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2742-2 · Cited by 53
Metadata
- Authors
- Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V.
- Affiliations
- Mayo Clinic (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-07-21
- Volume
- 353
- Issue
- 3
- Pages
- 249-254
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2134703404
- Semantic Scholar
- 0c597199a9be21ad0a99933c6f411731493880d4
- Cited by
- 779
- References
- 26
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 18 · 2022: 22 · 2021: 23 · 2020: 27 · 2019: 27 · 2018: 31 · 2017: 35 · 2016: 51 · 2015: 59 · 2014: 50 · 2013: 40 · 2012: 57
- FWCI
- 40.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (32385)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- hyperinsulinemic hypoglycemia, nesidioblastosis, Roux-en-Y gastric bypass, postprandial hypoglycemia, neuroglycopenia, partial pancreatectomy, insulinoma, obesity
- MeSH terms
- Adult, Female, Follow-Up Studies, Humans, Hyperinsulinism, Hyperplasia, Hypoglycemia, Insulinoma, Islets of Langerhans, Male, Middle Aged, Obesity, Obesity, Morbid, Pancreatic Ducts, Pancreatic Neoplasms, Postoperative Complications, Gastric Bypass, Postprandial Period, Nesidioblastosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.